Home › Funds › Freestone Capital Holdings, LLC › ABT

Freestone Capital Holdings, LLC position in ABT

ABBOTT LABORATORIES · Health Care

Freestone Capital Holdings, LLC reported holding 133,740 shares of ABT (ABBOTT LABORATORIES) in its Q2 2026 13F filing — a position valued at US$12.1M, representing 0.39% of its reported portfolio and ranking #41 among its reported holdings. Freestone Capital Holdings, LLC has disclosed ABT holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)133.74K sh
Reported value held$12.14M
Portfolio Weight0.39%
First reportedQ3 2023
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Freestone Capital Holdings, LLC's ABT position evolved

Freestone Capital Holdings, LLC first disclosed a stake in ABT in Q3 2023 at 113,193 shares (US$11.0M). The position peaked in Q1 2025 at 137,891 shares, worth US$18.3M. Across 12 filings, Freestone Capital Holdings, LLC increased the stake 7 time(s), trimmed it 2 time(s) and left it unchanged 2 time(s). The most recent filing (Q2 2026) shows 133,740 shares valued at US$12.1M — a reduction of -1,141 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 113.19K $10.96M New
Q4 2023 127.66K $14.05M Add
Q1 2024 131.68K $14.97M Add
Q2 2024 132.97K $13.82M Add
Q3 2024 134.90K $15.38M Add
Q4 2024 137.76K $15.58M Add
Q1 2025 137.89K $18.29M Hold
Q2 2025 127.45K $17.33M Reduce
Q3 2025 133.62K $17.90M Add
Q4 2025 134.16K $16.81M Hold
Q1 2026 134.88K $13.85M Add
Q2 2026 133.74K $12.14M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABT and 13F data

ABT (ABBOTT LABORATORIES) is a Health Care company. 20 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), Charles Schwab Investment Management (US$5.41B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABT

All ABT fund holders →

FAQ

How long has Freestone Capital Holdings, LLC held ABT?

Freestone Capital Holdings, LLC has disclosed ABT holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is Freestone Capital Holdings, LLC's current position in ABT?

As of Q2 2026, Freestone Capital Holdings, LLC holds 133.74K shares of ABT (ABBOTT LABORATORIES), valued at $12.14M, representing 0.39% of its reported portfolio and ranking #41.

Has Freestone Capital Holdings, LLC been buying or selling ABT?

In the latest 13F filing (Q2 2026), Freestone Capital Holdings, LLC reduced its position in ABT. The position peaked in Q1 2025 at 137.89K shares.

Which other funds hold ABT?

Other major institutional holders of ABT include Vanguard Group, Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 20 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.